Effect of Testosterone Replacement on Insulin Resistance in Hypogonadal, Non-Obese Men With Metabolic Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 22 Oct 2012
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 03 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2010 Planned end date changed from 1 Dec 2008 to 1 Oct 2010 as reported by ClinicalTrials.gov.